An Exploratory Study of Lurbinectedin With Radiotherapy in SCLC With Single-lesion Progression After First Course Treatment | MicrobiomeTrials← Back to trialsNCT06501976
An Exploratory Study of Lurbinectedin With Radiotherapy in SCLC With Single-lesion Progression After First Course Treatment
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2025-12-31Est. Completion: 2026-12
Enrollment target: 9 participants Locations- National Cancer Center/Cancer Hospital, Beijing, China
Other microbiome trials you might be interested in
Advanced/Metastatic Non-Small Cell Lung Cancer
This study will evaluate two study drugs called ubamatamab and REGN7075, to see if they can help treat advanced or metas…
Goodyear, United StatesEst. completion Jun 24, 2030
Advanced Lung Non-Squamous Non-Small Cell CarcinomaMetastatic Lung Non-Squamous Non-Small Cell CarcinomaRecurrent Lung Non-Squamous Non-Small Cell CarcinomaStage IIIB Lung Cancer AJCC v8Stage IV Lung Cancer AJCC v8
This phase III trial compares the effect of bevacizumab and osimertinib combination vs. osimertinib alone for the treatm…
Anchorage, United StatesEst. completion Dec 31, 2026